Using remote monitoring with community health workers to help Latinx patients manage hypertension
Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
This study tests whether using remote monitoring with the help of community health workers can better help Latinx patients manage their high blood pressure compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06730230 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a remote patient monitoring (RPM) program supported by community health workers (CHWs) in managing hypertension among Latinx patients. It employs a step-wedge randomized controlled trial design to compare the RPM-enabled CHW approach with standard care for hypertension management. The study will assess various outcomes including blood pressure reduction, implementation effectiveness, and factors such as adoption, acceptability, and sustainability of the RPM program.
Who should consider this trial
Good fit: Ideal candidates are Latinx individuals aged 18 and older with uncontrolled hypertension and non-adherence to prescribed antihypertensive medications.
Not a fit: Patients who are unable to comply with the study protocol or have significant psychiatric comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve blood pressure management and health outcomes for Latinx patients with hypertension.
How similar studies have performed: Other studies have shown promise in using community health workers and technology for chronic disease management, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Self-identify as Latinx 2. Be fluent in English or Spanish 3. Be age 18 years or older 4. Receiving care at one of the 10 safety-net primary care clinics 5. Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg) 6. Have been prescribed at least one anti-hypertensive medication and be non-adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR. Exclusion Criteria: 1. Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks) 2. Participation in other hypertension-related clinical trials 3. Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR) 4. Plan to discontinue care at the clinic within the next 15 months
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Devin Mann, MD — NYU Langone Health
- Study coordinator: Devin Mann, MD
- Email: Devin.Mann@nyulangone.org
- Phone: 212-263-8313
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.